Suppr超能文献

葫芦素——癌症治疗的一个有前景的靶点。

Cucurbitacins - a promising target for cancer therapy.

作者信息

Alghasham Abdullah A

机构信息

College of Medicine, Qassim University, Kingdom of Saudi Arabia.

出版信息

Int J Health Sci (Qassim). 2013 Jan;7(1):77-89. doi: 10.12816/0006025.

Abstract

During the last decades a large number of cucurbitacins have been isolated from various plant species belonging to other plant families than Cucurbitaceae. Although the roots and the fruits of plant belong to these Cucurbitaceae species are very bitter, they have been used as folk medicines in some countries because of their wide spectrum of pharmacological activities such as anti-inflammation and anticancer effects. In the last ten years, cucurbitacins had been shown to inhibit proliferation and induced apoptosis utilizing a long array of in vitro and in vivo cancer cell models. Several molecular targets for cucurbitacins have been discovered, such as fibrous-actin, signal transducer and activator of transcription (STAT), cyclooxygenase-2, etc. This review aimed at elucidating the natural sources of some cucurbitacin compounds, their chemical structure and derivatives, physical properties, biological activities and mechanism by which they reduce the proliferation human cancer cells. This widens our armaments against a devastating disease that we are failing to face.

摘要

在过去几十年里,人们从葫芦科以外的其他植物科的各种植物物种中分离出了大量的葫芦素。尽管这些葫芦科植物的根和果实非常苦,但由于它们具有广泛的药理活性,如抗炎和抗癌作用,在一些国家已被用作民间药物。在过去十年中,利用一系列体外和体内癌细胞模型,已证明葫芦素能抑制增殖并诱导凋亡。已经发现了葫芦素的几个分子靶点,如纤维肌动蛋白、信号转导和转录激活因子(STAT)、环氧化酶-2等。本综述旨在阐明一些葫芦素化合物的天然来源、它们的化学结构和衍生物、物理性质、生物活性以及它们减少人类癌细胞增殖的机制。这拓宽了我们对抗一种我们未能面对的毁灭性疾病的武器库。

相似文献

1
Cucurbitacins - a promising target for cancer therapy.
Int J Health Sci (Qassim). 2013 Jan;7(1):77-89. doi: 10.12816/0006025.
2
Recent Advances in the Application of Cucurbitacins as Anticancer Agents.
Metabolites. 2023 Oct 14;13(10):1081. doi: 10.3390/metabo13101081.
3
Biological activities and potential molecular targets of cucurbitacins: a focus on cancer.
Anticancer Drugs. 2012 Sep;23(8):777-87. doi: 10.1097/CAD.0b013e3283541384.
4
Potential of cucurbitacin as an anticancer drug.
Biomed Pharmacother. 2023 Dec;168:115707. doi: 10.1016/j.biopha.2023.115707. Epub 2023 Oct 18.
5
Cucurbitacin: ancient compound shedding new light on cancer treatment.
ScientificWorldJournal. 2010 Mar 5;10:413-8. doi: 10.1100/tsw.2010.44.
8
Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity.
Am J Chin Med. 2015;43(7):1331-50. doi: 10.1142/S0192415X15500755. Epub 2015 Oct 27.
10
Apoptotic and antimetastatic effect of cucurbitacins in cancer: recent trends and advancement.
Naunyn Schmiedebergs Arch Pharmacol. 2023 Sep;396(9):1867-1878. doi: 10.1007/s00210-023-02471-z. Epub 2023 Apr 3.

引用本文的文献

2
Profiling and cheminformatics bioprospection of curcurbitacin I and momordin Ic from on α-amylase and α-glucosidase.
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2492706. doi: 10.1080/14756366.2025.2492706. Epub 2025 Apr 29.
3
Current Insights into Therapeutic Potential of Terpenoids as Anticancer Agents.
Anticancer Agents Med Chem. 2025;25(5):339-356. doi: 10.2174/0118715206342920241008062115.
4
Role of the JAK2/STAT3 pathway on infection of Francisella novicida.
PLoS One. 2024 Sep 10;19(9):e0310120. doi: 10.1371/journal.pone.0310120. eCollection 2024.
6
Cucurbitacins mitigate vascular neointimal hyperplasia by suppressing cyclin A2 expression and inhibiting VSMC proliferation.
Animal Model Exp Med. 2024 Aug;7(4):397-407. doi: 10.1002/ame2.12457. Epub 2024 Jul 5.
7
Depolymerization of actin filaments by Cucurbitacin I through binding G-actin.
Food Sci Nutr. 2023 Nov 6;12(2):881-889. doi: 10.1002/fsn3.3804. eCollection 2024 Feb.
9
Recent Advances in the Application of Cucurbitacins as Anticancer Agents.
Metabolites. 2023 Oct 14;13(10):1081. doi: 10.3390/metabo13101081.

本文引用的文献

1
Biological activities and potential molecular targets of cucurbitacins: a focus on cancer.
Anticancer Drugs. 2012 Sep;23(8):777-87. doi: 10.1097/CAD.0b013e3283541384.
2
Synthesis and cytotoxic activity evaluation of dihydrocucurbitacin B and cucurbitacin B derivatives.
Bioorg Med Chem. 2012 May 1;20(9):3016-30. doi: 10.1016/j.bmc.2012.03.001. Epub 2012 Mar 15.
3
Cucurbitacins as inducers of cell death and a rich source of potential anticancer compounds.
Curr Pharm Des. 2012;18(12):1663-76. doi: 10.2174/138161212799958549.
8
Apoptosis induction through proteasome inhibitory activity of cucurbitacin D in human T-cell leukemia.
Cancer. 2011 Jun 15;117(12):2735-46. doi: 10.1002/cncr.25711. Epub 2010 Dec 23.
9
Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo.
Cancer Sci. 2008 Sep;99(9):1793-7. doi: 10.1111/j.1349-7006.2008.00899.x. Epub 2008 Jul 10.
10
Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21.
Biochem Pharmacol. 2008 Jul 15;76(2):198-207. doi: 10.1016/j.bcp.2008.05.004. Epub 2008 May 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验